---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-075242"
form_type: "8-K"
ticker: null
cik: "0001839998"
company_name: "American Oncology Network, Inc."
filed_at: "2023-06-27T23:59:59+00:00"
generated_at: "2026-06-13T16:31:14.896664+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Digital Transformation Opportunities Corp. extends business combination deadline to July 31, 2023 with $50k deposit

## Summary
- Sponsor deposited $50,000 into trust account to extend deadline from June 30 to July 31, 2023.
- Extension evidenced by a non-interest bearing, unsecured promissory note due upon business combination or liquidation.
- Company now has until July 31, 2023 to complete its initial business combination.

## SEC filing metadata
- accession: 0001104659-23-075242
- form_type: 8-K
- cik: 0001839998
- company_name: American Oncology Network, Inc.
- filed_at: 2023-06-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839998/000110465923075242/0001104659-23-075242-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839998/000110465923075242/tm2319760d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-075242
- JSON: https://secwatch.observer/filing/0001104659-23-075242.json
- Plain text: https://secwatch.observer/filing/0001104659-23-075242.txt

## Key facts
- Debt Financings
  American Oncology Network, Inc. incurred loan of $50,000 with Digital Transformation Sponsor LLC at no interest maturing upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company.
  - Instrument: loan
  - Principal: $50,000
  - Counterparty: Digital Transformation Sponsor LLC
  - Rate: no interest
  - Maturity: upon the earlier of (i) the date of the consummation of the Company’s initial business combination and (ii) the date of the liquidation of the Company
  - Event: incurrence
  source text: the Sponsor deposited $50,000 into the trust account established for the benefit of the Company’s public stockholders, which was evidenced by a non-interest bearing, unsecured promissory note issued in favor of the Sponsor (the “Extension Note”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000110465923075242/0001104659-23-075242-index.htm
- Material Agreements
  American Oncology Network, Inc. entered into Extension Note with Digital Transformation Sponsor LLC valued at $50,000 (effective 2023-06-24).
  - Action: entry
  - Counterparty: Digital Transformation Sponsor LLC
  - Value: $50,000
  - Effective: 2023-06-24
  source text: On June 24, 2023, Digital Transformation Sponsor LLC (the “Sponsor”) delivered written notice to Digital Transformation Opportunities Corp. (the “Company”), regarding its exercise of the option to extend the date by which the Company is required to complete its initial business combination from June 30, 2023 to July 31, 2023. In accordance with the Company’s charter, the Sponsor deposited $50,000 into the trust account established for the benefit of the Company’s public stockholders, which was evidenced by a non-interest bearing, unsecured promissory note issued in favor of the Sponsor (the “Extension Note”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839998/000110465923075242/0001104659-23-075242-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.